Literature DB >> 25489332

Two-vessel chronic total occlusion. Complete percutaneous revascularisation.

Artur Dębski1, Paweł Tyczyński1, Maksymilian P Opolski1, Mariusz Kłopotowski1, Maciej A Karcz1, Adam Witkowski1.   

Abstract

Little is known about the success rate of second attempts to open chronic total occlusions. Two-vessel occlusion makes the procedure is even more challenging. Thus, embarking on complete percutaneous revascularization of such lesions requires adequate experience, especially after first unsuccessful attempt. We present a case of a 52-year-old male patient in whom successful percutaneous opening of two chronic coronary at staged procedure was performed.

Entities:  

Keywords:  multiple chronic total occlusion; percutaneous coronary intervention

Year:  2014        PMID: 25489332      PMCID: PMC4252335          DOI: 10.5114/pwki.2014.46779

Source DB:  PubMed          Journal:  Postepy Kardiol Interwencyjnej        ISSN: 1734-9338            Impact factor:   1.426


Case report

A 52-year-old-patient with a history of previous myocardial infarction was scheduled for further diagnosis due to recurrent angina class CCS II/III. The echocardiography showed mildly impaired left ventricle systolic function, ejection fraction of 50%, and akinesia limited to mid segments of the inferior and lateral wall. Coronary angiography revealed chronic total occlusion (CTO) of both the left anterior descending coronary artery (LAD) and the left circumflex coronary artery (LCx) (Figure 1A) and non-significant lesions in the right coronary artery. The patient definitely refused the surgical treatment of coronary lesions. Thus, an attempt to open the LCx was carried out in a secondary center. Radial access was used to cannulate the left coronary artery with a JL 4.0 guide catheter. The LCx occlusion was crossed with Pilot 50 wire (Abbott Vasc, Santa Clara, USA). However, a 1.5 mm rapid exchange balloon was unable to follow the wire past the occlusion. The procedure was stopped and the patient has been referred to our department for further treatment.
Figure 1

A – CTO of the LAD and the LCx. B – LAD after opening and implantation of DES. C – CTO of LCx. D – LCx after opening and implantation of DES

CTO – chronic total occlusion, LAD – left anterior descending coronary artery, LCx – left circumflex coronary artery, DES – drug eluting stent

A – CTO of the LAD and the LCx. B – LAD after opening and implantation of DES. C – CTO of LCx. D – LCx after opening and implantation of DES CTO – chronic total occlusion, LAD – left anterior descending coronary artery, LCx – left circumflex coronary artery, DES – drug eluting stent At the first step, successful opening of the LAD with Sion Blue wire (Asahi Intecc, Japan) in the direction of diagonal branch was done. After unsuccessful negotiation of the distal LAD segment with Fielder XT wire (Asahi Intecc, Japan), Confianza wire (Asahi Intecc, Japan) was advanced via microcatheter Corsair (Asahi Intecc, Japan) and crossed the occlusion. After predilatation, a 3.0 × 38 mm everolimus eluting stent was implanted (Figure 1B). At staged procedure an AL2 guide catheter was used to cannulate the left coronary artery ostium. Fielder FC (Asahi Intecc, Japan) wire successfully negotiated through the LCx occlusion. Then a 1.2 mm MiniTrek Over The Wire balloon (Abbott Vasc, Santa Clara, USA) crossed the lesion. After predilatation, Sion Blue was advanced into the marginal branch. Finally, a 2.5 × 28 mm everolimus eluting stent at 14 atm was implanted (Figure 1C, D). For both coronaries TIMI 3 flow was noted at the end of the procedure. The total fluoroscopic time for both procedures was 60 min (2607 mGy). For both approaches, the femoral artery was used as a vascular access. The postprocedural course was uneventful.

Discussion

Multiple CTO is a rare finding as compared to single CTO and the prognosis with conservative treatment is poorer [1]. Surgical treatment is usually an attractive option for such patients unless lack of patient consent or contraindications necessitate a percutaneous approach. Successful percutaneous coronary intervention (PCI) of all CTOs is associated with increased survival, and complete of revascularisation is a strong predictor of survival [2]. However, scarce data are available regarding complete percutaneous revascularisation of multiple CTO. Furthermore a failed attempt to open CTO is a predictor of lower success rate of a second approach. In the J-CTO registry the success rate of first CTO attempt was as high as 88%. Repeat CTO attempt, however, was associated with only 65% success rate [3]. Wire failure to cross over the occlusion is the most common reason of unsuccessful CTO PCI. Ten–twenty percent of the CTO PCI failures are due to balloon un-crossable lesions. Methods to deal with such problem start with simple technical tips, like better guide catheter support and deep sitting or buddy wire. Radial access, which was used for the first attempt to open the CTO in our patient, may not provide sufficient back-up support. Although the femoral access is preferable for CTO PCI, single reports stress the value of a radial approach [4]. The use of more advanced techniques requires adequate experience and often referral to a higher volume operator (as in our case). These alternatives include “mother-and-child” technique, anchoring, Tornus catheter, etc. Finally due to the nature of CTO procedures, a staged approach is the logical choice. This lowers the risk of contrast-induced nephropathy (CIN) and possible X-ray related skin injury. In the aforementioned J-CTO registry, the total fluoroscopic time per patient was 45 min, the contrast volume was 293 ml, and the frequency of CIN was 1%. However, another Asian group reported the CIN rate at 5% [5]. The procedural outcomes of CTO PCI among the operators of the EuroCTO club are comparable to those reported in the Japanese registry [6].
  5 in total

1.  In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan).

Authors:  Yoshihiro Morino; Takeshi Kimura; Yasuhiko Hayashi; Toshiya Muramatsu; Masahiko Ochiai; Yuichi Noguchi; Kenichi Kato; Yoshisato Shibata; Yoshikazu Hiasa; Osamu Doi; Takehiro Yamashita; Takeshi Morimoto; Mitsuru Abe; Tomoaki Hinohara; Kazuaki Mitsudo
Journal:  JACC Cardiovasc Interv       Date:  2010-02       Impact factor: 11.195

2.  Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.

Authors:  Yu-Sheng Lin; Hsiu-Yu Fang; Hesham Hussein; Chih-Yuan Fang; Yung-Lung Chen; Shu-Kai Hsueh; Cheng-I Cheng; Cheng-Hsu Yang; Chien-Jen Chen; Chi-Ling Hang; Hon-Kan Yip; Chiung-Jen Wu
Journal:  EuroIntervention       Date:  2014-02       Impact factor: 6.534

3.  In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry.

Authors:  Alfredo R Galassi; Salvatore D Tomasello; Nicolaus Reifart; Gerald S Werner; George Sianos; Hans Bonnier; Horst Sievert; Stephan Ehladad; Alexander Bufe; Joachim Shofer; Anthony Gershlick; David Hildick-Smith; Javier Escaned; Andrejs Erglis; Imad Sheiban; Leif Thuesen; Anthony Serra; Evald Christiansen; Achim Buettner; Luca Costanzo; Giombattista Barrano; Carlo Di Mario
Journal:  EuroIntervention       Date:  2011-08       Impact factor: 6.534

4.  Prevalence, predictors and clinical impact of unique and multiple chronic total occlusion in non-infarct-related artery in patients presenting with ST-elevation myocardial infarction.

Authors:  Yoann Bataille; Jean-Pierre Déry; Eric Larose; Ugo Déry; Olivier Costerousse; Josep Rodés-Cabau; Stéphane Rinfret; Robert De Larochellière; Eltigani Abdelaal; Jimmy Machaalany; Gérald Barbeau; Louis Roy; Olivier F Bertrand
Journal:  Heart       Date:  2012-09-26       Impact factor: 5.994

5.  Percutaneous coronary intervention for multiple chronic total occlusions.

Authors:  Gian Battista Danzi; Renato Valenti; Angela Migliorini; Guido Parodi; Ruben Vergara; David Antoniucci
Journal:  Am J Cardiol       Date:  2013-09-21       Impact factor: 2.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.